Posted on 12 月 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on 12 月 21, 202112/21/21
Launch Sequencing and Market Prioritization in an Evolving Global Market
Posted on 12 月 6, 202112/6/21
Considering Commercial Success During Clinical Development: Maintaining a Global Perspective
Posted on 11 月 9, 202111/9/21
EPP Keynote Address: Global Pricing and Market Access Hurdles for Innovation
Posted on 11 月 4, 202111/4/21
Pharma Europe 2021 : Panel
Posted on 11 月 2, 202111/2/21
Bio-Europe “Collaboration Close-Up”: Exploring the EVERSANA – Shorla Pharma Partnership
Posted on 10 月 15, 202110/15/21
WEBINAR: Yes EU can! How novel treatments can avoid complexity and commercialize with impact across the European continent
Posted on 10 月 15, 202110/15/21
EPP Studio Live Webinar — Impact of COVID-19 Pandemic on German Healthcare System
Posted on 10 月 6, 202110/6/21
EPP Studio Live Webinar — EU Joint Procurement of COVID-19 Vaccines: A Model for Future Market Access in Europe?
Posted on 10 月 5, 202110/5/21